Authors:
PAGLIARO LC
LIU BS
MUNKER R
ANDREEFF M
FREIREICH EJ
SCHEINBERG DA
ROSENBLUM MG
Citation: Lc. Pagliaro et al., HUMANIZED M195 MONOCLONAL-ANTIBODY CONJUGATED TO RECOMBINANT GELONIN - AN ANTI-CD33 IMMUNOTOXIN WITH ANTILEUKEMIC ACTIVITY, Clinical cancer research, 4(8), 1998, pp. 1971-1976
Authors:
MUNKER R
ZHAO SR
JIANG SW
SNELL V
ANDREEFF M
ANDERSSON BS
Citation: R. Munker et al., FURTHER CHARACTERIZATION OF CYCLOPHOSPHAMIDE RESISTANCE - EXPRESSION OF CD95 AND OF BCL-2 IN A CML CELL-LINE, Leukemia research, 22(11), 1998, pp. 1073-1077
Authors:
GOESSL C
HEICAPPELL R
MUNKER R
ANKER P
STROUN M
KRAUSE H
MULLER M
MILLER K
Citation: C. Goessl et al., MICROSATELLITE ANALYSIS OF PLASMA DNA FROM PATIENTS WITH CLEAR-CELL RENAL-CARCINOMA, Cancer research, 58(20), 1998, pp. 4728-4732
Authors:
ASOU H
SAID JW
YANG R
MUNKER R
PARK DJ
KAMADA N
KOEFFLER HP
Citation: H. Asou et al., MECHANISMS OF GROWTH-CONTROL OF KAPOSIS SARCOMA-ASSOCIATED HERPES VIRUS-ASSOCIATED PRIMARY EFFUSION LYMPHOMA-CELLS, Blood, 91(7), 1998, pp. 2475-2481
Authors:
MUNKER R
KANTARJIAN H
OBRIEN S
KEATING M
ANDREEFF M
ESTEY EH
Citation: R. Munker et al., PHASE-I STUDY OF TAXOL IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIAS USING A WEEKLY SCHEDULE, Acta haematologica, 99(2), 1998, pp. 106-108
Citation: R. Munker et al., SOLUBLE CD95 IN THE SERUM OF PATIENTS WITH LOW AND INTERMEDIATE GRADEMALIGNANT-LYMPHOMAS - ABSENCE OF PROGNOSTIC CORRELATIONS, Leukemia & lymphoma, 27(5-6), 1997, pp. 517-521
Citation: Sw. Jiang et al., BCL-2 IS EXPRESSED IN HUMAN NATURAL-KILLER-CELLS AND IS REGULATED BY INTERLEUKIN-2, Natural immunity, 15(6), 1997, pp. 312-317
Citation: R. Munker et M. Andreeff, INDUCTION OF DEATH (CD95 FAS), ACTIVATION AND ADHESION (CD54) MOLECULES ON BLAST CELLS OF ACUTE MYELOGENOUS LEUKEMIAS BY TNF-ALPHA AND IFN-GAMMA/, Cytokines and molecular therapy, 2(3), 1996, pp. 147-159
Citation: R. Munker et al., 2ND MALIGNANCIES - CLINICAL RELEVANCE AND BASIC RESEARCH (REVIEW), International journal of oncology, 9(4), 1996, pp. 763-776
Citation: R. Munker et al., SOLUBLE FAS (CD95) IS NOT ELEVATED IN THE SERUM OF PATIENTS WITH MYELOID LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC SYNDROMES, Leukemia, 10(9), 1996, pp. 1531-1533
Authors:
STABLER A
BAUR A
BARTL R
MUNKER R
LAMERZ R
REISER MF
Citation: A. Stabler et al., CONTRAST ENHANCEMENT AND QUANTITATIVE SIGNAL ANALYSIS IN MR-IMAGING OF MULTIPLE-MYELOMA - ASSESSMENT OF FOCAL AND DIFFUSE GROWTH-PATTERNS IN MARROW CORRELATED WITH BIOPSIES AND SURVIVAL RATES, American journal of roentgenology, 167(4), 1996, pp. 1029-1036
Authors:
MUNKER R
STOTZER O
DARSOW M
CLASSEN S
LEBEAU A
WILMANNS W
Citation: R. Munker et al., AUTOANTIBODIES AGAINST P53 ARE NOT INCREASED IN HUMAN ASCITES AND PLEURAL EFFUSIONS, Cancer immunology and immunotherapy, 42(3), 1996, pp. 200-201
Authors:
MUNKER R
KOBAYASHI T
ELSTNER E
NORMAN AW
USKOKOVIC M
ZHANG W
ANDREEFF M
KOEFFLER HP
Citation: R. Munker et al., A NEW SERIES OF VITAMIN-D ANALOGS IS HIGHLY-ACTIVE FOR CLONAL INHIBITION, DIFFERENTIATION, AND INDUCTION OF WAF1 IN MYELOID-LEUKEMIA, Blood, 88(6), 1996, pp. 2201-2209
Authors:
LISOVSKY M
ESTROV Z
ZHANG X
CONSOLI U
SANCHEZWILLIAMS G
SNELL V
MUNKER R
GOODACRE A
SAVCHENKO V
ANDREEFF M
Citation: M. Lisovsky et al., FLT3 LIGAND STIMULATES PROLIFERATION AND INHIBITS APOPTOSIS OF ACUTE MYELOID-LEUKEMIA CELLS - REGULATION OF BCL-2 AND BAX, Blood, 88(10), 1996, pp. 3987-3997
Authors:
MUNKER R
SCHMIDT M
CHRISTEL K
HOLZEL D
HILLER E
Citation: R. Munker et al., 2ND MALIGNANCIES IN PATIENTS WITH HODGKIN S-DISEASE IN FULL REMISSION- INTERIM RESULTS, Deutsche Medizinische Wochenschrift, 120(3), 1995, pp. 51-54